Form 4: Olaplex Director Deirdre Findlay Granted RSUs

Olaplex Holdings, Inc. Director Deirdre Findlay was granted 110,294 restricted stock units, vesting in 2026.

Summary

• Deirdre Findlay, a Director of Olaplex Holdings, Inc. (OLPX), was granted 110,294 shares of common stock.
• The grant occurred on August 12, 2025, and was reported on August 14, 2025.
• These shares are Restricted Stock Units (RSUs) under the company's 2021 Equity Incentive Plan.
• Each RSU represents the conditional right to receive one share of common stock.
• The RSUs will vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, contingent on Ms. Findlay's continued service.
• Following this transaction, Ms. Findlay beneficially owns 248,693 shares.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is a positive sign of aligning interests and retaining talent, but it's a routine compensation event rather than a significant strategic announcement.

Positives

• Grant of 110,294 Restricted Stock Units (RSUs) to a director aligns her interests with shareholders.
• The RSUs are granted at a price of $0, indicating a direct equity incentive.
• The vesting schedule through the 2026 Annual Meeting of Stockholders promotes long-term commitment and retention of key leadership.

Negatives

• No immediate cash benefit from the RSU grant as they are unvested.
• The value of the RSUs is subject to future stock price performance.

Risks

• The value of the RSU grant is subject to the future performance of Olaplex's common stock.
• Vesting is contingent on continued service, meaning the RSUs could be forfeited if the director's service ends before the vesting date.

Future Outlook

The RSUs are set to vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent on the reporting person's continued service. This indicates a future commitment and incentive structure for the director.

Industry Context

This is a standard insider compensation disclosure. Equity grants like RSUs are common practice in publicly traded companies to align director and executive interests with long-term shareholder value. Olaplex operates in the beauty and haircare industry, where attracting and retaining experienced leadership is crucial.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to directors is a common compensation practice across various industries, including consumer goods and beauty, aligning director incentives with long-term company performance.
• A $0 grant price for RSUs is standard, as these are typically performance or time-based equity awards rather than purchases.
• The vesting schedule tied to future annual meetings (e.g., 2026 Annual Meeting) is a typical retention mechanism, similar to practices at companies like Estée Lauder (EL) or L'Oréal (OR) which also use long-term incentive plans for their leadership.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with long-term shareholder value, as the value of the RSUs depends on the company's stock performance.
• Management: The grant is part of the compensation structure for a director, indicating continued commitment from leadership.

Next Steps

• Continued service of Deirdre Findlay to Olaplex Holdings, Inc. until the 2026 Annual Meeting of Stockholders for full RSU vesting.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a director, which is a standard compensation practice aimed at aligning insider interests with long-term shareholder value. It does not contain any new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide a basis for a 'buy' or 'sell' decision.

Keywords

Olaplex, OLPX, Form 4, Insider Trading, Restricted Stock Units, RSU, Equity Incentive Plan, Director Compensation, Stock Grant, Corporate Governance